Clinical value for contrast-enhanced transrectal ultrasound in diagnosis of prostate cancer / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 882-885, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-813180
ABSTRACT
To explore the value for contrast-enhanced transrectal ultrasound (CETRUS) in the diagnosis of prostate cancer.
Methods:
Prostate biopsy from 207 cases of suspected prostate cancer were collected between January 2013 and March 2015. These patients were performed ultrasound-guided prostate biopsy in Central Hospital of Changsha. They were randomly divided into a radiography group (n=104) and a non-radiography group (n=103) according to the order of treatment. Transrectal ultrasonography (TRUS) was the first choice in the 2 groups, and CETRUS was conducted in the radiography group. Then, the transrectal biopsy was carried out in the 2 groups. The diagnostic value of CETRUS in prostate cancer was evaluated by pathological examination, a gold standard.Results:
The sensitivity, specificity, and coincidence rates of TRUS in diagnosing prostate cancer were 65%, 60.4%, and 62.8%, respectively, while those rates of CETRUS in diagnosing prostate cancer were 89%, 78%, and 84%, respectively, with significant difference between the above 2 groups (all P<0.05).Conclusion:
The sensitivities, specificities, and coincidence rates for CETRUS are superior to TRUS in diagnosing prostate cancer, which can provide a clinical basis for the diagnosis and differential diagnosis of prostate cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Prostate
/
Prostatic Neoplasms
/
Diagnostic Imaging
/
Radiography, Interventional
/
Ultrasonography
/
Sensitivity and Specificity
/
Contrast Media
/
Endoscopic Ultrasound-Guided Fine Needle Aspiration
/
Methods
Type of study:
Diagnostic study
Limits:
Humans
/
Male
Language:
Chinese
Journal:
Journal of Central South University(Medical Sciences)
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS